Episodic Falling Syndrome in Cavalier King Charles Spaniels: Genetic Testing & Management

Key Statistics & Research Data

• Genetic cause: Episodic Falling Syndrome (EFS) in [Cavalier King Charles](https://seniorpet.org/knowledge/breed/cavalier-king-charles-spaniel "Senior Cavalier King Charles Spaniel Health Guide") Spaniels is associated with a mutation in the brevican (BCAN) gene and follows an autosomal recessive inheritance pattern (BCAN mutation; affected = two copies) (breed genetic studies; commercial test providers).
• Typical age of onset: most affected CKCS first show signs between 3–7 months of age; later onset has been documented (cases reported >1 year) (multiple clinical case series).
• Presentation prevalence: clinical disease is uncommon but not rare in CKCS; surveys and testing programs report disease prevalence estimates of roughly 1–5% of dogs, with carrier rates substantially higher (see carrier frequency) (breed surveys, DNA testing registries).
• Carrier frequency: population surveys and testing programs in different countries report carrier frequencies in CKCS in the approximate range of 15–30% (varies by region and breeding pool) (Kennel Club/ breed health surveys; diagnostic lab registries).
• Diagnostic accuracy: a validated DNA test for the BCAN mutation is commercially available and can reliably identify clear/carrier/affected dogs; combining DNA testing with video documentation of episodes improves diagnostic confidence (genetic test providers; peer-reviewed reports).
• Misdiagnosis risk: EFS is a paroxysmal exercise-induced dystonia — not epilepsy — and may be misinterpreted as seizure disorder; EEG is typically normal and consciousness is usually preserved during episodes (clinical reviews).
• Response to therapy: pharmacologic management (e.g., clonazepam, acetazolamide) plus trigger-avoidance has enabled many affected CKCS to have meaningful [quality of life](https://seniorpet.org/knowledge/[siamese](https://seniorpet.org/knowledge/breed/siamese "Senior Siamese Cat Health Guide")-cat-quality-of-life "Quality of Life Assessment"); some dogs show reduced frequency/severity of episodes with age (case series and clinical reports).
• Testing impact on breeding: widespread use of DNA testing in breeding programs has been effective at reducing the number of affected puppies when used with responsible mate selection (breed club reports and breeding guidelines).

Sources: The Kennel Club (UK) Breed Health resources; commercial veterinary genetic testing laboratories (BCAN/EFS test); peer-reviewed veterinary neurology and breed-specific clinical case reports on CKCS EFS and paroxysmal exercise-induced dystonia.

Note: exact percentages and prevalence vary by country, study population and year; owners should consult up-to-date results from national breed health surveys and diagnostic labs for their region.

> 📖 Recommended Reading: For the complete picture of senior pet health management, read [our comprehensive senior dog care guide](/knowledge/ultimate-guide-senior-dog-care) for detailed protocols, statistics, and actionable advice.

What is Episodic Falling Syndrome (EFS) in Cavalier King Charles Spaniels?

Episodic Falling Syndrome (EFS) is a breed-specific, genetically mediated movement disorder seen primarily in Cavalier King Charles Spaniels (CKCS). It is a paroxysmal exercise-induced dystonia: brief, involuntary increases in muscle tone and abnormal posturing triggered most commonly by exercise, excitement, stress or heat. Importantly, EFS is not an epileptic seizure disorder — most affected dogs remain aware and responsive during episodes.

In CKCS, EFS has been linked to a mutation in the BCAN gene (brevican), and the condition is inherited in an autosomal recessive manner. Affected dogs have two copies of the mutant allele; carriers (one copy) are clinically normal but can pass the mutation to offspring.

Genetics: BCAN Mutation and Autosomal Recessive Inheritance

• Causative gene: BCAN (brevican), a gene expressed in the nervous system and involved in extracellular matrix components that support neuronal function and motor control.
• Inheritance pattern: autosomal recessive. Clinically affected dogs are homozygous for the mutant BCAN allele. Heterozygous carriers are typically clinically normal.
• Breeding implications: mating two carriers has a 25% chance of producing an affected puppy, 50% chance of producing carriers and 25% chance of producing clear puppies. Because carriers are common in many CKCS populations (carrier frequency often reported in the teens to low dozens of percent), genetic testing is a critical tool to reduce incidence.

Genetic testing for the BCAN mutation is widely available from veterinary genetic laboratories. Tests classify dogs as Clear/Normal (no mutation), Carrier (one copy), or Affected (two copies). Results provide definitive information about a dog’s genetic status for EFS and are essential for responsible breeding decisions.

Pathophysiology: Paroxysmal Exercise-Induced Dystonia (Not Epilepsy)

• Nature of episodes: sudden, paroxysmal increases in skeletal muscle tone, abnormal limb posture (often described as “deer-stalking”), and altered gait patterns such as “bunny-hopping.” Episodes can progress to a collapse-like posture without loss of consciousness.
• Mechanism: the BCAN mutation is thought to disrupt extracellular matrix components needed for normal neuronal signalling in motor pathways, predisposing to abnormal motor output during high demand (exercise/excitement). The condition fits the category of paroxysmal non-epileptic movement disorder — specifically paroxysmal exercise-induced dystonia (PED).
• Differentiation from seizures: in EFS consciousness is usually preserved, post-ictal confusion is absent, and EEG (if performed) does not show epileptiform activity. Episodes are commonly reproducible with particular triggers (exercise/excitement) rather than random, generalized seizures.

Typical Triggers

• Vigorous exercise (running, playing) — classic trigger
• Excitement (greeting owners, intense play)
• Emotional stress or sudden arousal
• Heat or high ambient temperature (may exacerbate episodes)
• Sometimes prolonged anticipation (e.g., before mealtime or walks)

Avoiding or modifying these triggers is a central component of management.

Clinical Signs & Episode Description

Common clinical features in CKCS with EFS:

• Increased muscle tone (rigidity) beginning in the pelvic limbs and sometimes progressing to thoracic limbs.
• “Deer-stalking” posture: one or both hind limbs extended in a sustained, hyperextended posture.
• “Bunny-hopping” or simultaneous hopping of both hind limbs during episodes.
• Collapse with preserved consciousness (dog remains aware, often responsive to voice or visual cues).
• Duration: episodes usually last seconds to a few minutes (rarely longer).
• Frequency: highly variable — from rare isolated events to clusters daily or during active periods.
• Onset: typically 3–7 months of age, but later onset is reported.
• No post-ictal disorientation or loss of bladder/bowel control typical of generalized seizures.

Because clinical appearance can mimic seizure or orthopedic collapse, accurate diagnosis requires careful assessment and documentation.

Diagnosis

A stepwise diagnostic approach tailored to CKCS:

Clinical history and owner interview

- Detailed description of episodes: what triggers them, how long they last, whether consciousness seems preserved, and any progression over time. - Age at first episode — typical onset 3–7 months is highly suggestive.

Video documentation

- Owners should record clear, close-up video of several typical episodes. Video is one of the most valuable diagnostic tools and helps differentiate EFS from epilepsy, collapse due to cardiac disease, or orthopaedic causes.

Genetic testing (definitive)

- DNA test for the BCAN mutation is available commercially and reliably identifies Clear / Carrier / Affected status. A positive (affected) result in a clinically symptomatic dog confirms the diagnosis when the clinical picture fits. - Testing is essential for breeding decisions and should be performed on all breeding stock and on clinically suspect animals.

Neurologic workup when needed

- If the clinical picture is atypical, or if other neurologic diseases are possible, veterinarians may perform a neurological examination, imaging (MRI) to rule out structural disease (e.g., syringomyelia, although syringomyelia is a separate, important issue in CKCS), or routine labs. EEG is not routinely diagnostic for EFS but may help rule out epilepsy in ambiguous cases.

Rule-outs

- Cardiac syncope, orthopaedic collapse, metabolic causes (hypoglycemia, electrolyte disturbances), and true epileptic seizures should be considered and excluded as appropriate.

Combining owner video with genetic testing is the most efficient and breed-specific diagnostic pathway.

Treatment & Management

There is no cure that reverses the genetic defect, but many affected CKCS respond to a combination of trigger management, lifestyle modification, and medical therapy. Treatment goals are to reduce episode frequency and severity and to maintain quality of life.

Non-pharmacologic strategies (first-line, breed-specific):

• Avoid or modify triggers:

- Shorter, gentler exercise sessions rather than prolonged running. - Avoid intense play sessions that provoke episodes. - Minimize exposure to heat; provide cool environments during activity. - Reduce exciting situations where possible (structured greetings, calmer introductions).

• Conditioning and pacing:

- Gradual increase in activity under controlled conditions; use of leash walks rather than off-leash sprinting.

• Environmental adjustments:

- Air conditioning or fans in warm weather, access to shade, and prompt cooling after exertion.

Pharmacologic options (used in CKCS EFS under veterinary supervision):

• Clonazepam (benzodiazepine)

- Mechanism: enhances GABAergic inhibition, can reduce hypertonic motor episodes. - Clinical notes: many clinicians report clonazepam can reduce episode frequency and severity in EFS-affected CKCS. Use requires veterinary prescription, monitoring for sedation or tolerance.

• Acetazolamide (carbonic anhydrase inhibitor)

- Mechanism: alters neuronal membrane excitability via metabolic effects; can reduce frequency of paroxysmal movement episodes in some dogs. - Clinical notes: sometimes used when benzodiazepines are insufficient or as adjunctive therapy.

• Other agents

- In refractory cases, veterinarians may trial other antispasmodics or neuromodulatory drugs; however, efficacy varies and evidence is largely from case series rather than randomized trials.

Important: all medication choices, dosing and monitoring must be directed by a veterinary neurologist or primary care veterinarian experienced with CKCS EFS. Side effects (sedation, GI upset, idiosyncratic reactions) must be considered. Owners should never use human medications without veterinary guidance.

Surgical or curative therapies are not available for BCAN-associated EFS.

Prognosis

• Variable but often favorable with management. Many CKCS experience a reduction in episode frequency and severity as they age (some owners report fewer episodes after 1–2 years of age), though this is not universal.
• With appropriate avoidance of triggers and medical therapy when needed, many affected dogs maintain good quality of life and normal life expectancy.
• Severe, refractory cases can be very distressing and may require aggressive management; [euthanasia](https://seniorpet.org/knowledge/when-to-consider-euthanasia-quality-of-life "When to Consider Euthanasia") is rarely necessary when appropriate supportive care and medical therapy are available, but quality-of-life considerations vary by case.

Breeding Recommendations & Population Health

Because EFS is autosomal recessive and carriers are common in many CKCS populations, responsible breeding is essential:

• Test all potential breeding stock for the BCAN mutation.
• Do not breed two carriers together; this pairing risks 25% affected puppies.
• Preferential matings: Carrier x Clear/Normal is acceptable only when guided by an overall breeding plan to reduce carrier frequency over time; ideally, select Clear/Normal x Clear/Normal matings.
• Maintain genetic diversity: while selecting against the mutation is important, breeders should also consider other breed health concerns (e.g., [mitral valve disease](https://seniorpet.org/knowledge/cavalier-king-charles-spaniel-mitral-valve-disease "Mitral Valve Disease Guide"), syringomyelia) and avoid extreme reductions in diversity that can worsen other inherited problems. Working with breed clubs and veterinary geneticists is recommended.
• Register results and participate in breed health surveys to track progress and inform national strategies.

Breed clubs and kennel organizations have published specific guidelines — owners and breeders should follow current national recommendations.

Monitoring and When to Seek Veterinary Help

• Record episodes with video and note triggers, duration, and any changes in pattern. Bring videos to the veterinarian.
• Seek veterinary care promptly if: episodes become more frequent or prolonged, consciousness appears to be lost, there are additional neurologic deficits, or if collapse occurs without clear triggers. These signs warrant urgent assessment to rule out other diseases.
• If your dog is genetically affected and being medically managed, maintain regular veterinary follow-up to assess treatment efficacy and side effects.

Table — Comparison: EFS Episode Features vs Typical Generalized Seizure (CKCS Context)

| Feature | Episodic Falling Syndrome (EFS) | Generalized Seizure | |---|---:|---| | Consciousness during event | Usually preserved / responsive | Often lost or markedly decreased | | Typical triggers | Exercise, excitement, stress, heat | Often none or random | | Onset age in CKCS | Typically 3–7 months (but variable) | Any age depending on cause | | Duration | Seconds to a few minutes | Usually 1–3 minutes (post-ictal phase follows) | | Post-event behavior | Normal immediately after | Post-ictal disorientation, lethargy, pacing | | EEG findings | Typically normal | May show epileptiform activity | | Confirmatory test | BCAN DNA test + video | EEG, diagnostic workup for underlying causes |

Practical Owner Guidance (Breed-Specific)

• If you suspect EFS: get clear, well-lit video of multiple episodes; arrange DNA testing for the BCAN mutation; consult your veterinarian or a veterinary neurologist familiar with CKCS.
• Modify activity patterns immediately: avoid sprinting and prolonged play, maintain cool conditions, and introduce calm greetings.
• If medication is recommended, follow dosing and monitoring plans exactly and report side effects promptly.
• Connect with CKCS breed clubs and support resources; many clubs provide breeder directories, health testing guidance and experienced owner networks.

Key Takeaways

• EFS in Cavalier King Charles Spaniels is a paroxysmal exercise-induced dystonia linked to an autosomal recessive BCAN gene mutation; it is a movement disorder, not epilepsy.
• Typical first signs appear between 3–7 months of age, though later onset can occur. Episodes are commonly triggered by exercise, excitement, stress or heat, and dogs usually retain consciousness.
• A validated DNA test for the BCAN mutation is available and is the definitive tool for diagnosis and essential for responsible breeding. Video documentation of episodes greatly aids clinical diagnosis.
• Management centers on trigger avoidance, lifestyle modification and targeted medications such as clonazepam or acetazolamide under veterinary supervision; many CKCS improve with combined strategies.
• Carrier frequencies in CKCS vary by population (commonly reported in the mid-teens to low-twenties percent range); testing and informed breeding decisions substantially reduce affected puppies in the long term.
• Prognosis is variable but many affected CKCS maintain good quality of life; some dogs show decreased episode frequency with age. Early diagnosis and a tailored management plan improve outcomes.
• Work with your veterinarian and breed club resources to test breeding stock, interpret results, and integrate EFS management into comprehensive CKCS health care.

References and resources for owners and breeders (examples; check regional updates):

• The Kennel Club (UK) — Breed health information and genetic testing guidance.
• Veterinary genetic test providers (BCAN/EFS test; diagnostic lab result registries).
• Veterinary neurology clinical reviews and CKCS breed health survey reports.

If you’d like, I can: (1) provide a printable checklist for video documentation and sample questions to take to your veterinarian, (2) summarize current U.S./UK testing laboratories for BCAN DNA testing, or (3) draft a breeder-friendly mating plan template that balances EFS risk reduction with genetic diversity.